Our cardiac meds – in real life, not just in studies

by Carolyn Thomas    @HeartSisters

If you – like me – have had a heart attack, you are now likely taking a fistful of medications each morning, everything from anti-platelet drugs to help prevent a new blockage from forming inside your metal stent to meds that can help lower your blood pressure or manage your LDL cholesterol numbers. All of these cardiac drugs have been studied by researchers before being approved by government regulators as being safe and effective for us to take every day.

But one particular study on this subject published in the Journal of the American College of Cardiology(1) has raised a unique point:

“Little is known about the benefits and risks of longterm use of cardiovascular drugs. Clinical trials rarely go beyond a few years of follow-up, but patients are often given continuous treatment with multiple drugs well into old age.”  

Continue reading “Our cardiac meds – in real life, not just in studies”

Deprescribing: fewer drugs, better health outcomes?

by Carolyn Thomas    @HeartSisters

We all know about prescribing. It’s what our docs do when they pull out the prescription pad so we can start or keep taking a specific drug for a specific medical reason.

But what about deprescribing?

Basically, deprescribing happens when a health care professional decides to taper or stop recommending one or more prescription drugs for any given patient. The practice is aimed at minimizing what’s known as polypharmacy (that’s when patients are taking multiple medications at the same time) while at the same time improving patient outcomes.

What’s the problem with polypharmacy? Plenty, as it turns out.
Continue reading “Deprescribing: fewer drugs, better health outcomes?”

What your cardiologist (should have) learned last month

by Carolyn Thomas  @HeartSisters

After a bunch of top cardiologists got together in San Francisco recently for the annual American College of Cardiology scientific meetings, Debra Sherman and her team did a fine job summing up highlights for Reuters.*  One of their first take-home messages: some cardiologists believe that drug prescribing has gotten out of hand.  Continue reading “What your cardiologist (should have) learned last month”